XJPX
4061
Market cap1.77bUSD
Oct 09, Last price
3,248.00JPY
1D
0.31%
1Q
-16.99%
Jan 2017
25.89%
Name
Denka Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Denka Company Limited, an enterprise based in Tokyo, Japan, and established in 1915, operates as a global producer and purveyor of a diverse range of organic and inorganic materials. Its extensive product portfolio caters primarily to the electronics and pharmaceutical sectors. The company's operations are segmented into several key divisions. The Electronics & Innovative Products segment is dedicated to developing and supplying advanced components such as conductive agents crucial for lithium-ion batteries, along with thermal management materials, specialized substrates, high-performance ceramics, and various films and tapes. Under its Life Innovation division, Denka plays a significant role in public health, offering influenza vaccines, producing rapid diagnostic kits – including those for identifying novel coronavirus antigens – and providing macromolecular sodium hyaluronate preparations. The Elastomers & Infrastructure Solutions arm encompasses a variety of products, ranging from specialized functional elastomers and cement additives to agricultural essentials like fertilizers and corrugated pipes. Finally, the Polymer Solutions division focuses on synthetic materials, featuring styrene-based resins, food packaging sheets, and synthetic fibers utilized in wigs and hairpieces, alongside poval and other diverse chemical offerings. Originally founded in 1915 as Denki Kagaku Kogyo Kabushiki Kaisha, the company adopted its current name, Denka Company Limited, in October 2015.
Key people
Ikuo Ishida
President, Executive President, Representative Director · since 2025
Masahide Yamada
Executive Officer, Chief Scientific Officer, Manager of New Business Development, Manager of Innovation Center · since 2025
Yukio Sasagawa
Managing Executive Officer, Manager of Gosen Business Center · since 2024
Kazuya Tokumoto
Managing Executive Officer, President of Subsidiary · since 2024
Hideki Toya
Chief Scientific Officer, Managing Executive Officer, Manager of New Business Development Division, Manager of Innovation Center · since 2024
Akinori Adachi
Executive Officer · since 2024
Takeshi Hagiwara
Executive Officer, Omi Plant Manager · since 2023
Kei Hara
Executive Officer, Manager of Polymer Solutions Division · since 2023
Hiroto Horiuchi
Executive Officer, Manager of Electronics & Innovative Products Division · since 2023
Taro Inada
Executive Officer, Manager of Life Innovation Division · since 2024
Akira Kasahara
Executive Officer, Director of Account · since 2025
Masahiro Kawai
Executive Officer, Chiba Plant Manager · since 2023
Muneatsu Miida
Executive Officer, President of Subsidiary · since 2025
Koji Nishimura
Executive Officer, Omuta Plant Manager · since 2024
Tetsuo Noguchi
Executive Officer, Shibukawa Plant Manager · since 2023
Masahiro Omata
Executive Officer, Manager of Elastomers & Infrastructure Solutions Division · since 2023
Koya Takahashi
Executive Officer, Manager of Elastomers & Infrastructure Solutions · since 2025
Ken Watanabe
Executive Officer, Assistant Manager of New Business Development Division · since 2024
Director · since 2025
Toshio Imai
Chairman of the Board, Representative Director · since 2025
Headquarters & legal address
日本橋室町二丁目1番1号
東京都 中央区 103-8338
JP
東京都 中央区 103-8338
JP
Address
1-1,Nihonbashi-Muromachi 2-chome
Chuo-ku Tokyo 103-8338
JP
Chuo-ku Tokyo 103-8338
JP
Other language
Denka Company Limited
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||